Study of Dasatinib vs Imatinib in Patients With Chronic Myeloid Leukemia (CML) Who Did Not Have Favorable Response to Imatinib
Clinical trial NCT01593254 · COMPLETED
Trial details
- NCT number
- NCT01593254
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-12
- Primary completion
- 2017-11-08
- Enrollment
- 262
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.